Angioedema Treatment Market 2020, Size, Largest Share, Emerging countries, Engagement strategy, Dynamic, Current Trends, Multiple Application, Supply Demand Approach and Regional Forecast to 2026

SEATTLE, March 24, 2021, (PHARMIWEB) — Global Angioedema Treatment Market

Angioedema is a medical condition characterized by swelling of the lower layer of skin and tissue just under the skin or mucous membrane. The condition is caused by various factors, and in most cases, the exact cause is unknown. The four main types of angioedema include allergic angioedema, drug-induced angioedema, idiopathic angioedema, and hereditary angioedema (HAE). Major causes of angioedema include allergic reactions, adverse effects of a particular medication, genetic defects, and infections.

To learn more about this report, request a sample copy*
* The sample copy includes: Report Summary, Table of Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.

Request a sample copy of this report@ https://www.coherentmarketinsights.com/insight/request-sample/1371

Frequent approval of novel drugs from regulatory bodies expected to boost the growth of the global angioedema treatment market

In 2017, the U.S. Food and Drug Administration (FDA) approved Haegarda, which is a C1 Esterase Inhibitor (Human) for subcutaneous administration indicated for the preventing hereditary angioedema (HAE) in adult and adolescent patients. Furthermore, in 2014, Pharming Group NV and Salix Pharmaceuticals, Ltd. received the U.S. FDA approval for RUCONEST (C1 Esterase Inhibitor [Recombinant]) 50 IU/kg, indicated for the treatment of acute angioedema attacks in adult and adolescent patients with HAE.

In 2016, CSL Behring received FDA approval for Berinert [C1 Esterase Inhibitor (Human)], indicated for the treatment of HAE attacks in pediatric patients. These multiple approvals of new drugs by regulatory bodies are expected to drive growth of global angioedema treatment market over the forecast period. Moreover, the initiatives taken by various organizations to support the treatment of angioedema are also expected to support the growth of the global angioedema treatment market. In 2015, the British Society for Allergy and Clinical Immunology (BSACI) provided a guideline for the management of chronic urticaria and angioedema.

Exclusive offer!!! Purchase the report at a discounted rate!!!

Apply Promo Code “CMIFIRST1000” and Get Up to 30% Discount

Quick Buy – Angioedema Treatment Market Research Report: https://bit.ly/3rgDT9d

Global Angioedema Treatment Market Taxonomy

By Condition Type:

• Allergic angioedema
• Drug-induced angioedema
• Idiopathic angioedema
• Hereditary angioedema (HAE)

By Drug Type:

• C1 Esterase inhibitor
  • Cinryze
  • Berinert
  • Ruconest
  • Haegarda
• Selective Bradykinin B2 receptor antagonist
  • Firazyr
• Kallikrein inhibitor
  • Kalbitor
• Others

By Route of Administration:

• Injection
  • Intravenous
  • Subcutaneous
• Oral

By Distribution Channel:

• Hospitals
• Retail pharmacies
• Online pharmacies

Get Sample PDF Brochure with Impact of COVID19: https://www.coherentmarketinsights.com/insight/request-pdf/1371

Geographical Outlook

The angioedema treatment market in Europe is expected show significant growth in the following years, owing to the growing presence of leading manufacturers of angioedema therapeutics. For instance in January 2018, Shire Plc received the U.S. FDA approval for the technology transfer of CINRYZE (C1 esterase inhibitor [human]) drug product manufacturing process to its Vienna and Austria manufacturing sites. CINRYZE is an injectable prescription medicine indicated for the treatment of HAE in teenagers and adults.

On the other hand, North America is expected to hold the dominant position in the global angioedema treatment market, due to the approval of new drugs indicated for the treatment of angioedema. For instance in 2014, Shire Canada Inc. received approval for its FIRAZYR (icatibant injection) in Canada. FIRAZYR is indicated for the treatment of acute attacks of HAE in adults with C1-esterase inhibitor deficiency.

Multinational Players

The key players participating in the global angioedema treatment market include Shire Plc, CSL Limited, Pharming Group NV, Ionis Pharmaceuticals, Inc., iBio Inc., and BioCryst Pharmaceuticals, Inc.

Browse Global Strategic Business Report: https://www.coherentmarketinsights.com/ongoing-insight/angioedema-treatment-market-1371

Table of Content

Global Angioedema Treatment Market Research Report
Section 1: Global Angioedema Treatment Industry Overview
Section 2: Global Economic Impact on Angioedema Treatment Industry
Section 3: Global Market Competition by Industry Producers
Section 4: Global Productions, Revenue (Value), according to Regions
Section 5: Global Supplies (Production), Consumption, Export, Import, geographically
Section 6: Global Productions, Revenue (Value), Price Trend, Product Type
Section 7: Global Market Analysis, on the basis of Application
Section 8: Angioedema Treatment Market Pricing Analysis
Section 9: Market Chain, Sourcing Strategy and Downstream Buyers
Section 10: Strategies and key policies by Distributors/Suppliers/Traders
Section 11: Key Marketing Strategy Analysis, by Market Vendors
Section 12: Market Effect Factors Analysis
Section 13: Global Angioedema Treatment Market Forecast

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.

To know more about us, please visit our website – www.coherentmarketinsights.com

Contact:

Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837